Home / Companies / Company Results /  Suven Pharma Q2 net profit declines 20% at 74 crore

Drug firm Suven Pharmaceuticals on Friday reported a 20.35% decline in its consolidated net profit at 74.07 crore for the quarter ended September 30, 2020.

The company had posted a net profit of 93 crore for the corresponding period of the previous fiscal, Suven Pharmaceuticals said in a filing to BSE.

Consolidated total income of the company stood at 237.74 crore for the quarter under consideration. It was 278.37 crore for the same period year ago, it added.

"The board has allotted the bonus shares at 1:1 ratio in its meeting held on September 29, 2020," the filing said.

The board has approved capital expenditure (capex) plan of 600 crore keeping in view of the proposed increase in capacity in Pashamylaram facility, replacement and modernization of production blocks in Suryapet facility, relocation of R&D facilities from Jeedimetla and acquisition of new technologies, it added.

Shares of Suven Pharmaceuticals were trading at 308.70 per scrip on BSE, down 8.86% from its previous close.

This story has been published from a wire agency feed without modifications to the text. Only the headline has been changed.

Subscribe to Mint Newsletters
* Enter a valid email
* Thank you for subscribing to our newsletter.
Recommended For You
Edit Profile
Get alerts on WhatsApp
Set Preferences My ReadsFeedbackRedeem a Gift CardLogout